Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Raptis

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Oncology Research|June 15, 2016
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First RelapseAnnie Im, Ali Amjad, Mounzer Agha, et al.
Oncology Research|August 6, 2020
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete RemissionArisha Patel, Mounzer Agha, Anastasios Raptis, et al.
Hematological Oncology|July 1, 2017
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemiaMatthew J Lim, Aya Agha, Annie Im, et al.
Leukemia Research|July 22, 2016
ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemiaBobbi Hartsock, Matthew J Lim, Christine Garcia Roth, et al.
Clinical Transplantation|July 16, 2017
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantationKonstantinos Lontos, Mounzer Agha, Anastasios Raptis, et al.
Leukemia & Lymphoma|September 8, 2022
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AMLKonstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 25, 2021
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapyChristi McKeown, Asha Ricciuti, Mounzer Agha, et al.
Leukemia & Lymphoma|February 1, 2023
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsyKonstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
American Journal of Hematology|January 23, 2024
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patientsAnnie Im, Kevin Quann, Mounzer Agha, et al.
Leukemia & Lymphoma|April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemiaRobert L Redner, Jan H Beumer, Patricia Kropf, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Oncology Research|June 15, 2016
Mitoxantrone and Etoposide for the Treatment of Acute Myeloid Leukemia Patients in First RelapseAnnie Im, Ali Amjad, Mounzer Agha, et al.
Oncology Research|August 6, 2020
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete RemissionArisha Patel, Mounzer Agha, Anastasios Raptis, et al.
Hematological Oncology|July 1, 2017
Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemiaMatthew J Lim, Aya Agha, Annie Im, et al.
Leukemia Research|July 22, 2016
ICU intervention during induction chemotherapy for adult patients with newly diagnosed acute myeloid leukemiaBobbi Hartsock, Matthew J Lim, Christine Garcia Roth, et al.
Clinical Transplantation|July 16, 2017
Outcomes of patients diagnosed with acute myeloid leukemia after solid organ transplantationKonstantinos Lontos, Mounzer Agha, Anastasios Raptis, et al.
Leukemia & Lymphoma|September 8, 2022
A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AMLKonstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 25, 2021
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapyChristi McKeown, Asha Ricciuti, Mounzer Agha, et al.
Leukemia & Lymphoma|February 1, 2023
Prognostic significance of blast immunophenotype on first post-induction bone marrow biopsyKonstantinos Lontos, Anastasia Tsagianni, Mounzer Agha, et al.
American Journal of Hematology|January 23, 2024
Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patientsAnnie Im, Kevin Quann, Mounzer Agha, et al.
Leukemia & Lymphoma|April 5, 2018
A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemiaRobert L Redner, Jan H Beumer, Patricia Kropf, et al.
Pageof 6